מרונם 500 מג

Država: Izrael

Jezik: hebrejski

Izvor: Ministry of Health

Kupi sada

Aktivni sastojci:

MEROPENEM AS TRIHYDRATE

Dostupno od:

PFIZER PFE PHARMACEUTICALS ISRAEL LTD

ATC koda:

J01DH02

Farmaceutski oblik:

אבקה להכנת תמיסה לזריקה

Sastav:

MEROPENEM AS TRIHYDRATE 500 MG/VIAL

Administracija rute:

תוך-ורידי

Tip recepta:

מרשם נדרש

Proizveden od:

ASTRA ZENECA UK LIMITED

Terapijska grupa:

MEROPENEM

Područje terapije:

MEROPENEM

Terapijske indikacije:

Meronem is indicated for treatment in adults and children of the following severe infections caused by single or multiple susceptible bacteria sensitive to meropenem: - Pneumonias and nosocomial pneumonias. - Pulmonary infections in patients with cystic fibrosis. - Urinary tract infections. - Intra-abdominal infections. - Gynecological infections such as endometritis and pelvic inflammatory disease. - Skin and skin structure infections. - Meningitis. - Septicemia. Meronem has proved efficacious alone or in combination with other antimicrobial agents in the treatment of polymicrobial infections. There is no experience in pediatric patients with neutropenia or primary or secondary immunodeficiency.

Datum autorizacije:

2012-01-31

Dokumenti na drugim jezicima

Uputa o lijeku Uputa o lijeku engleski 17-08-2016
Svojstava lijeka Svojstava lijeka engleski 03-06-2020
Izvješće o ocjeni javnog Izvješće o ocjeni javnog engleski 17-08-2016

Upozorenja za pretraživanje vezana za ovaj proizvod

Pogledajte povijest dokumenata